Tenecteplase to treat pulmonary embolism in the emergency department

Jeffrey Kline, Jackeline Hernandez-Nino, Alan E. Jones

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Tenecteplase, a mutant form of alteplase, possesses pharmacological properties that might favor its use for emergent fibrinolysis of acute pulmonary embolism. Contemporaneous search of the World's literature reveals 14 humans with acute pulmonary embolism treated with tenecteplase. Here, we summarize those cases and report the presentation features, dosing details and outcomes of eight additional patients with acute pulmonary embolism treated with tenecteplase in an academic emergency department. None of our eight patients had a significant hemorrhagic event after tenecteplase, and the outcomes of all eight appear to be acceptable. Taken together, we submit that the present case report and prior case reports are sufficient to comprise a phase I study of the safety and efficacy of tenecteplase to treat acute pulmonary embolism.

Original languageEnglish (US)
Pages (from-to)101-105
Number of pages5
JournalJournal of Thrombosis and Thrombolysis
Volume23
Issue number2
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Pulmonary Embolism
Hospital Emergency Service
Fibrinolysis
Tissue Plasminogen Activator
tenecteplase
Pharmacology
Safety

Keywords

  • Fibrinolysis
  • Outcome
  • Pulmonary embolism
  • Tenecteplase

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Tenecteplase to treat pulmonary embolism in the emergency department. / Kline, Jeffrey; Hernandez-Nino, Jackeline; Jones, Alan E.

In: Journal of Thrombosis and Thrombolysis, Vol. 23, No. 2, 04.2007, p. 101-105.

Research output: Contribution to journalArticle

Kline, Jeffrey ; Hernandez-Nino, Jackeline ; Jones, Alan E. / Tenecteplase to treat pulmonary embolism in the emergency department. In: Journal of Thrombosis and Thrombolysis. 2007 ; Vol. 23, No. 2. pp. 101-105.
@article{1b5fef56e009494bb66aeb69ff34af24,
title = "Tenecteplase to treat pulmonary embolism in the emergency department",
abstract = "Tenecteplase, a mutant form of alteplase, possesses pharmacological properties that might favor its use for emergent fibrinolysis of acute pulmonary embolism. Contemporaneous search of the World's literature reveals 14 humans with acute pulmonary embolism treated with tenecteplase. Here, we summarize those cases and report the presentation features, dosing details and outcomes of eight additional patients with acute pulmonary embolism treated with tenecteplase in an academic emergency department. None of our eight patients had a significant hemorrhagic event after tenecteplase, and the outcomes of all eight appear to be acceptable. Taken together, we submit that the present case report and prior case reports are sufficient to comprise a phase I study of the safety and efficacy of tenecteplase to treat acute pulmonary embolism.",
keywords = "Fibrinolysis, Outcome, Pulmonary embolism, Tenecteplase",
author = "Jeffrey Kline and Jackeline Hernandez-Nino and Jones, {Alan E.}",
year = "2007",
month = "4",
doi = "10.1007/s11239-006-9018-3",
language = "English (US)",
volume = "23",
pages = "101--105",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Tenecteplase to treat pulmonary embolism in the emergency department

AU - Kline, Jeffrey

AU - Hernandez-Nino, Jackeline

AU - Jones, Alan E.

PY - 2007/4

Y1 - 2007/4

N2 - Tenecteplase, a mutant form of alteplase, possesses pharmacological properties that might favor its use for emergent fibrinolysis of acute pulmonary embolism. Contemporaneous search of the World's literature reveals 14 humans with acute pulmonary embolism treated with tenecteplase. Here, we summarize those cases and report the presentation features, dosing details and outcomes of eight additional patients with acute pulmonary embolism treated with tenecteplase in an academic emergency department. None of our eight patients had a significant hemorrhagic event after tenecteplase, and the outcomes of all eight appear to be acceptable. Taken together, we submit that the present case report and prior case reports are sufficient to comprise a phase I study of the safety and efficacy of tenecteplase to treat acute pulmonary embolism.

AB - Tenecteplase, a mutant form of alteplase, possesses pharmacological properties that might favor its use for emergent fibrinolysis of acute pulmonary embolism. Contemporaneous search of the World's literature reveals 14 humans with acute pulmonary embolism treated with tenecteplase. Here, we summarize those cases and report the presentation features, dosing details and outcomes of eight additional patients with acute pulmonary embolism treated with tenecteplase in an academic emergency department. None of our eight patients had a significant hemorrhagic event after tenecteplase, and the outcomes of all eight appear to be acceptable. Taken together, we submit that the present case report and prior case reports are sufficient to comprise a phase I study of the safety and efficacy of tenecteplase to treat acute pulmonary embolism.

KW - Fibrinolysis

KW - Outcome

KW - Pulmonary embolism

KW - Tenecteplase

UR - http://www.scopus.com/inward/record.url?scp=33947268076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947268076&partnerID=8YFLogxK

U2 - 10.1007/s11239-006-9018-3

DO - 10.1007/s11239-006-9018-3

M3 - Article

C2 - 17221330

AN - SCOPUS:33947268076

VL - 23

SP - 101

EP - 105

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 2

ER -